Menzies Research Institute Tasmania, Hobart, Australia.
University of Ghent, Ghent, Belgium.
Eur Heart J Cardiovasc Imaging. 2015 Jun;16(6):577-605. doi: 10.1093/ehjci/jev076.
Hypertension remains a major contributor to the global burden of disease. The measurement of blood pressure continues to have pitfalls related to both physiological aspects and acute variation. As the left ventricle (LV) remains one of the main target organs of hypertension, and echocardiographic measures of structure and function carry prognostic information in this setting, the development of a consensus position on the use of echocardiography in this setting is important. Recent developments in the assessment of LV hypertrophy and LV systolic and diastolic function have prompted the preparation of this document. The focus of this work is on the cardiovascular responses to hypertension rather than the diagnosis of secondary hypertension. Sections address the pathophysiology of the cardiac and vascular responses to hypertension, measurement of LV mass, geometry, and function, as well as effects of treatment.
高血压仍然是全球疾病负担的主要原因之一。血压的测量仍然存在与生理方面和急性变化相关的缺陷。由于左心室（LV）仍然是高血压的主要靶器官之一，并且超声心动图对结构和功能的测量在这种情况下具有预后信息，因此制定关于在这种情况下使用超声心动图的共识立场非常重要。最近在评估 LV 肥厚和 LV 收缩和舒张功能方面的发展促使编写了本文件。这项工作的重点是心血管对高血压的反应，而不是继发性高血压的诊断。各部分内容涉及高血压对心脏和血管反应的病理生理学、LV 质量、几何形状和功能的测量以及治疗效果。
